REQUEST A DEMO
Total
USD $0.00
Search more companies

Kpa Pharma Sdn. Bhd. (Malaysia)

Main Activities: Medical Equipment and Supplies Manufacturing | Pharmacies and Drug Stores | Other Management Consulting Services
Full name: Kpa Pharma Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Other management consultancy activities n.e.c;stores specialized in retail sale of pharmaceuticals, medical and orthopaedic goods;export and import of medical and dental instrument and supplies

Headquarters
No. 9150, Jalan Bandar 4, Taman Melawati
Kuala Lumpur; Federal Territories; Postal Code: 53100

Contact Details: Purchase the Kpa Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Kpa Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Kpa Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
July 19, 2019
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Kpa Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
92.52%
Total operating revenue
92.52%
Operating profit (EBIT)
3.46%
EBITDA
5.69%
Net Profit (Loss) for the Period
3.46%
Total assets
38.58%
Total equity
-11.02%
Operating Profit Margin (ROS)
0.59%
Net Profit Margin
0.59%
Return on Equity (ROE)
-0.97%
Quick Ratio
-0.08%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?